Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia

Conditions:   Dyskeratosis Congenita;   Aplastic Anemia
Interventions:   Drug: Alemtuzumab;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation;   Biological: Stem Cell Transplant;   Drug: Anti-thymocyte globulin
Sponsor:   Masonic Cancer Center, University of Minnesota
Recruiting - verified August 2016